Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VRCI Verde Science’s Research and Development Program
Currently the company is working on starting a Research and Development initiative in Canada upon becoming licenced. In the meantime, the company is beginning a THC Pharmaceutical Development Program to be run through its alliance with the Institute of Chemical Technology in Mumbai, India. The program will include executing comprehensive research to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs.
The expansion of Verde Science’s Research and Development capabilities will be led and driven by Manit Patel, our Chief Technology Officer with the assistance of Dr. Ratnesh Jain and Dr. Prajatka Dandekar Jain. Both doctors earned their Ph.D.’s in Pharmacology from the Institute of Chemical Technology, with a research focus along the entire spectrum of Chemical Engineering.
Their research into the development and design of novel drug delivery mechanisms will have significant applications in the nascent field of Medical Marijuana treatment. This could also be applied to clinical trials aimed at determining proper dosing and drug formulations for various specific medical issues. Their research on nanoparticles will also have relevance in the study of medical uses of THC and cannabinoids, and nanoparticles of hemp.
VRCI Verde Science’s Research and Development Program
Currently the company is working on starting a Research and Development initiative in Canada upon becoming licenced. In the meantime, the company is beginning a THC Pharmaceutical Development Program to be run through its alliance with the Institute of Chemical Technology in Mumbai, India. The program will include executing comprehensive research to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs.
The expansion of Verde Science’s Research and Development capabilities will be led and driven by Manit Patel, our Chief Technology Officer with the assistance of Dr. Ratnesh Jain and Dr. Prajatka Dandekar Jain. Both doctors earned their Ph.D.’s in Pharmacology from the Institute of Chemical Technology, with a research focus along the entire spectrum of Chemical Engineering.
Their research into the development and design of novel drug delivery mechanisms will have significant applications in the nascent field of Medical Marijuana treatment. This could also be applied to clinical trials aimed at determining proper dosing and drug formulations for various specific medical issues. Their research on nanoparticles will also have relevance in the study of medical uses of THC and cannabinoids, and nanoparticles of hemp.
$XTRM Joeseph Spadafore, President of Extreme Biodiesel stated, "Extreme has been preparing for the drought for sometime now. XTRM has been on a waiting list for a well for several months and restrictions to drilling stalled the Company's development of its Hemp to Biodiesel project, but we have just turned a corner. The Drilling Company "Daugherty Pump and Drilling" has recently been able to pull the required permit to start the well and we anticipate being able to ramp up construction efforts on our land project very soon. Because of our early efforts to seek a well, the Company feels it should not be affected by the restrictions recently imposed by Gov. Brown."
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$XTRM Joeseph Spadafore, President of Extreme Biodiesel stated, "Extreme has been preparing for the drought for sometime now. XTRM has been on a waiting list for a well for several months and restrictions to drilling stalled the Company's development of its Hemp to Biodiesel project, but we have just turned a corner. The Drilling Company "Daugherty Pump and Drilling" has recently been able to pull the required permit to start the well and we anticipate being able to ramp up construction efforts on our land project very soon. Because of our early efforts to seek a well, the Company feels it should not be affected by the restrictions recently imposed by Gov. Brown."
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
Check out the CEO letter here http://ih.advfn.com/p.php?pid=nmona&article=66265564
$STOY
$VMRI As a member, Valmie plans to attend the upcoming AUVSI Unmanned Systems 2015 conference in May where it will build relationships with leaders in the space and introduce its new V-1 Drone.
$XTRM News alert!!!
XTRM News alert!!!
$UPPR is uniquely poised to take advantage of the fast paced changes that dominate the internet and technology sectors. The company makes tactical and intelligent acquisitions in high growth businesses and industries based exclusively on a commitment to investor trust and functional value.
$UPPR is uniquely poised to take advantage of the fast paced changes that dominate the internet and technology sectors. The company makes tactical and intelligent acquisitions in high growth businesses and industries based exclusively on a commitment to investor trust and functional value.
Could break 100K in volume before lunch! Should hit some trader radars IMO!
STOY
$XTRM getting a ton of tweets!!!
$XTRM getting a ton of tweets!!!
$XTRM Huge volume on news!!!
$XTRM Huge volume on news!!!
VRCI News! Verde adds Shantesh Hede, Ph.D As Director of Product Development
From Penny Stock Mobsters
Verde Science adds Shantesh Hede, Ph.D As Director of Product Development
LAS VEGAS, NV / ACCESSWIRE / April 10, 2015 / (VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh Hede, Ph.D. as Director of Product Development. Dr. Hede will be based in Mumbai, India and will direct Verde Science's R&D programs on-site with Verde's Research and Development partner, the Institute of Chemical Technology. He earned a Ph.D. in Bioengineering Systems from the MIT Portugal Program, a Master of Engineering Management from Duke University, and a Bachelors in Pharmaceutical Sciences from the Institute of Chemical Technology.
Dr. Hede stated, "Verde Science is uniquely positioned to leverage its R&D platform alliances with existing partners in healthcare institutions, academia and the pharmaceutical industry for the identification and commercialization of specific formulations derived from the marijuana plant for the treatment of numerous medical conditions. I look forward to being a part of this exciting effort and focusing Verde's scientific activities on applications that will produce significant intellectual property in areas of limited market
competition to produce substantial value for our shareholders."
About Verde Science, Inc. (PINKSHEETS:VRCI)
Verde Science, Inc. (trading symbol PINKSHEETS:VRCI) is an early stage pharmaceutical organization that has built a research team focused on developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of medical conditions. Verde's scientists have identified a number of promising areas in which to begin its immediate R&D program, which will initially be based in India. The Verde Science team of inter-disciplinary researchers includes scientists in Bioprocess Engineering, Nanotechnology, Molecular Biology, Pharmaceutical Sciences and Bio-Medical Devices that is focused on a streamlined approach to the development of innovative treatment protocols aimed at capturing considerable market share.
Information
For further information please see our investor profile available on our website:
www.verdescienceinc.com.
Louis Silver, Director of Investor Relations
Tel: 1-610-710-1303
lsilver@verdescienceinc.com
VRCI News! Verde adds Shantesh Hede, Ph.D As Director of Product Development
From Penny Stock Mobsters
Verde Science adds Shantesh Hede, Ph.D As Director of Product Development
LAS VEGAS, NV / ACCESSWIRE / April 10, 2015 / (VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh Hede, Ph.D. as Director of Product Development. Dr. Hede will be based in Mumbai, India and will direct Verde Science's R&D programs on-site with Verde's Research and Development partner, the Institute of Chemical Technology. He earned a Ph.D. in Bioengineering Systems from the MIT Portugal Program, a Master of Engineering Management from Duke University, and a Bachelors in Pharmaceutical Sciences from the Institute of Chemical Technology.
Dr. Hede stated, "Verde Science is uniquely positioned to leverage its R&D platform alliances with existing partners in healthcare institutions, academia and the pharmaceutical industry for the identification and commercialization of specific formulations derived from the marijuana plant for the treatment of numerous medical conditions. I look forward to being a part of this exciting effort and focusing Verde's scientific activities on applications that will produce significant intellectual property in areas of limited market
competition to produce substantial value for our shareholders."
About Verde Science, Inc. (PINKSHEETS:VRCI)
Verde Science, Inc. (trading symbol PINKSHEETS:VRCI) is an early stage pharmaceutical organization that has built a research team focused on developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of medical conditions. Verde's scientists have identified a number of promising areas in which to begin its immediate R&D program, which will initially be based in India. The Verde Science team of inter-disciplinary researchers includes scientists in Bioprocess Engineering, Nanotechnology, Molecular Biology, Pharmaceutical Sciences and Bio-Medical Devices that is focused on a streamlined approach to the development of innovative treatment protocols aimed at capturing considerable market share.
Information
For further information please see our investor profile available on our website:
www.verdescienceinc.com.
Louis Silver, Director of Investor Relations
Tel: 1-610-710-1303
lsilver@verdescienceinc.com
$VRCI ~ Leading Cutting Edge Research for the Isolation of Highly effective Formulations for the Treatment of Chronic Medical Disorders
>> http://verdescienceinc.com/
$VRCI ~ Leading Cutting Edge Research for the Isolation of Highly effective Formulations for the Treatment of Chronic Medical Disorders
>> http://verdescienceinc.com/
$XTRM The 25% cut in usage amounts to roughly 1.5 million acre-feet of water over the next nine months, state officials said.
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$XTRM The 25% cut in usage amounts to roughly 1.5 million acre-feet of water over the next nine months, state officials said.
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$UPPR advisors here: http://upperstreetmarketing.com/advisors/
1.01 on the ask!! She's really clearing out
UPPR
$UPPR - Upper Street Marketing capitalizes on their management expertise and industry insights to acquire and accelerate start-ups and existing businesses poised for explosive growth. Made up of an experienced team of visionaries, operators and action-oriented executives, Upper Street is uniquely poised to take advantage of the fast paced changes that dominate the internet and technology sectors.
$UPPR - Upper Street Marketing capitalizes on their management expertise and industry insights to acquire and accelerate start-ups and existing businesses poised for explosive growth. Made up of an experienced team of visionaries, operators and action-oriented executives, Upper Street is uniquely poised to take advantage of the fast paced changes that dominate the internet and technology sectors.
$UPPR Latest Cheatsheet
http://www.barchart.com/cheatsheet.php?sym=UPPR
$UPPR Latest Cheatsheet
http://www.barchart.com/cheatsheet.php?sym=UPPR
Clearing out some!! Here we go
STOY
$XTRM check out the website here http://www.extremebiodiesel.com/
$XTRM check out the website here http://www.extremebiodiesel.com/
$VRCI Verde has assembled a highly experienced, well-funded team that will deploy state-of-the-art technology and a superior growing methodology – aeroponics – to enter and take a meaningful market share.
$VRCI Verde has assembled a highly experienced, well-funded team that will deploy state-of-the-art technology and a superior growing methodology – aeroponics – to enter and take a meaningful market share.
$XTRM drill rights approved
http://stockcharts.com/c-sc/sc?s=XTRM&p=D&yr=0&mn=6&dy=0&i=t16107319028&r=1428670864618
"has recently been able to pull the required permit to start the well"
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$XTRM drill rights approved
http://stockcharts.com/c-sc/sc?s=XTRM&p=D&yr=0&mn=6&dy=0&i=t16107319028&r=1428670864618
"has recently been able to pull the required permit to start the well"
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$XTRM drill rights approved, one to watch! 50ma bounce, high vol drop yest
http://stockcharts.com/c-sc/sc?s=XTRM&p=D&yr=0&mn=6&dy=0&i=t16107319028&r=1428670864618
"has recently been able to pull the required permit to start the well"
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$XTRM drill rights approved, one to watch! 50ma bounce, high vol drop yest
http://stockcharts.com/c-sc/sc?s=XTRM&p=D&yr=0&mn=6&dy=0&i=t16107319028&r=1428670864618
"has recently been able to pull the required permit to start the well"
http://finance.yahoo.com/news/california-issues-mandatory-water-restrictions-120000396.html
$VRCI Verde Science, initial primary area of investigation is Cannabis-based extracts to isolate and develop formulations for the effective treatment of specific medical conditions such as, migraines and pain management, loss of appetite due to chemotherapy treatment, multiple sclerosis, and seizures.
$VRCI Verde Science, initial primary area of investigation is Cannabis-based extracts to isolate and develop formulations for the effective treatment of specific medical conditions such as, migraines and pain management, loss of appetite due to chemotherapy treatment, multiple sclerosis, and seizures.
$VRCI Product - http://verdescienceinc.com/product/medicinal-marijuana/